NCT02287623View on ClinicalTrials.gov

Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

October 31, 2014

Conditions
Acute Pain
Interventions
DRUG

liposomal bupivacaine

patients will receive a tap with liposomal bupivacaine

DRUG

bupivacaine

patients will receive a tap with bupivacaine

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02287623 - Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study | Biotech Hunter | Biotech Hunter